NO974267L - Aminotetralinderivat for behandling av kardiovaskulære sykdommer - Google Patents

Aminotetralinderivat for behandling av kardiovaskulære sykdommer

Info

Publication number: NO974267L
Authority: NO; Norway
Prior art keywords: treatment; cardiovascular diseases; aminotetraline; derivative; aminotetraline derivative
Prior art date: 1995-03-17

Application number

NO974267A

Other languages

English (en)

Other versions

NO317402B1 (no

NO974267D0 (no

Inventor

Paolo Chiesi

Stefano Bongrani

Roberta Razzetti

Maurizio Civelli

Alberto Umile

Original Assignee

Chiesi Farma Spa

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1995-03-17

Filing date

1997-09-16

Publication date

1997-11-07

1997-09-16 Application filed by Chiesi Farma Spa filed Critical Chiesi Farma Spa

1997-09-16 Publication of NO974267D0 publication Critical patent/NO974267D0/no

1997-11-07 Publication of NO974267L publication Critical patent/NO974267L/no

2004-10-25 Publication of NO317402B1 publication Critical patent/NO317402B1/no

Links

JRZGPXSSNPTNMA-UHFFFAOYSA-N 1,2,3,4-tetrahydronaphthalen-1-amine Chemical class C1=CC=C2C(N)CCCC2=C1 JRZGPXSSNPTNMA-UHFFFAOYSA-N 0.000 title 1
208000024172 Cardiovascular disease Diseases 0.000 title 1
208000020446 Cardiac disease Diseases 0.000 abstract 1
206010007559 Cardiac failure congestive Diseases 0.000 abstract 1
206010019280 Heart failures Diseases 0.000 abstract 1
OMMYLOLVPCCZQZ-UHFFFAOYSA-N [6-(methylamino)-1-(2-methylpropanoyloxy)-5,6,7,8-tetrahydronaphthalen-2-yl] 2-methylpropanoate Chemical compound C1=CC(OC(=O)C(C)C)=C(OC(=O)C(C)C)C2=C1CC(NC)CC2 OMMYLOLVPCCZQZ-UHFFFAOYSA-N 0.000 abstract 1
208000019622 heart disease Diseases 0.000 abstract 1
239000008194 pharmaceutical composition Substances 0.000 abstract 1
238000002560 therapeutic procedure Methods 0.000 abstract 1

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
- A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
- A61K31/22—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin
- A61K31/222—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin with compounds having aromatic groups, e.g. dipivefrine, ibopamine
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/13—Amines
- A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/13—Amines
- A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
- A61K31/136—Amines having aromatic rings, e.g. ketamine, nortriptyline having the amino group directly attached to the aromatic ring, e.g. benzeneamine
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
- A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
- A61K31/22—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin
- A61K31/221—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin with compounds having an amino group, e.g. acetylcholine, acetylcarnitine
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/55—Protease inhibitors
- A61K38/556—Angiotensin converting enzyme inhibitors
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/04—Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Public Health (AREA)
Chemical & Material Sciences (AREA)
Medicinal Chemistry (AREA)
Pharmacology & Pharmacy (AREA)
Veterinary Medicine (AREA)
Animal Behavior & Ethology (AREA)
General Health & Medical Sciences (AREA)
Epidemiology (AREA)
Engineering & Computer Science (AREA)
Bioinformatics & Cheminformatics (AREA)
Cardiology (AREA)
Emergency Medicine (AREA)
Vascular Medicine (AREA)
Heart & Thoracic Surgery (AREA)
Chemical Kinetics & Catalysis (AREA)
General Chemical & Material Sciences (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Organic Chemistry (AREA)
Gastroenterology & Hepatology (AREA)
Immunology (AREA)
Proteomics, Peptides & Aminoacids (AREA)
Hospice & Palliative Care (AREA)
Urology & Nephrology (AREA)
Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)

NO19974267A 1995-03-17 1997-09-16 Anvendelse av aminotetralinderivat eller et farmasoytisk akseptabelt salt derav og farmasoytiske sammensetninger inneholdende det samme ved behandling av kongestiv hjertesvikt NO317402B1 (no)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
IT95MI000532A IT1275935B1 (it)	1995-03-17	1995-03-17	Derivato di aminotetralina per la terapia di malattie cardiovascolari
PCT/EP1996/001060 WO1996029065A2 (en)	1995-03-17	1996-03-13	Aminotetralin derivative for the therapy of cardiovascular diseases

Publications (3)

Publication Number	Publication Date
NO974267D0 NO974267D0 (no)	1997-09-16
NO974267L true NO974267L (no)	1997-11-07
NO317402B1 NO317402B1 (no)	2004-10-25

Family

ID=11370947

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
NO19974267A NO317402B1 (no)	1995-03-17	1997-09-16	Anvendelse av aminotetralinderivat eller et farmasoytisk akseptabelt salt derav og farmasoytiske sammensetninger inneholdende det samme ved behandling av kongestiv hjertesvikt

Country Status (31)

Country	Link
US (2)	US6013678A (no)
EP (2)	EP1216702A3 (no)
JP (1)	JPH11502211A (no)
KR (1)	KR100391143B1 (no)
CN (1)	CN1112920C (no)
AT (1)	ATE218856T1 (no)
AU (1)	AU702656B2 (no)
BR (1)	BR9607996A (no)
CA (1)	CA2215671A1 (no)
CZ (1)	CZ288488B6 (no)
DE (1)	DE69621786T2 (no)
DK (1)	DK0814791T3 (no)
EA (1)	EA000937B1 (no)
EE (1)	EE04040B1 (no)
ES (1)	ES2177769T3 (no)
HK (1)	HK1048060A1 (no)
HU (1)	HUP9801686A3 (no)
IL (1)	IL117518A (no)
IT (1)	IT1275935B1 (no)
LT (1)	LT4355B (no)
LV (1)	LV11882B (no)
MX (1)	MX9706971A (no)
NO (1)	NO317402B1 (no)
NZ (1)	NZ303993A (no)
PL (1)	PL183347B1 (no)
PT (1)	PT814791E (no)
SI (1)	SI9620036B (no)
SK (1)	SK282952B6 (no)
TR (1)	TR199700963T1 (no)
WO (1)	WO1996029065A2 (no)
ZA (1)	ZA962073B (no)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
JP2695157B2 (ja) *	1986-12-29	1997-12-24	松下電器産業株式会社	可変パイプラインプロセッサ
WO2000076544A1 (en) *	1996-03-13	2000-12-21	Chiesi Farmaceutici S.P.A.	Aminotetralin derivative for the therapy of cardiovascular diseases
SI1183046T1 (en) *	1999-06-09	2004-02-29	Chiesi Farmaceutici S.P.A.	Aminotetralin derivative for the therapy of cardiovascular diseases
CN1354676A (zh) *	1999-06-09	2002-06-19	奇斯药制品公司	用于心血管疾病疗法的氨基四氢化萘衍生物
IT1313583B1 (it) *	1999-07-30	2002-09-09	Chiesi Farma Spa	Derivati 2-amminotetralinici per la terapia del glaucoma.
IL152751A0 (en) *	2000-05-12	2003-06-24	Chiesi Farma Spa	Optically active 2-aminotetralin derivatives, the processes for the preparation thereof and the therapeutical use of pharmaceutical compositions containing them
SE0101854L (sv) *	2001-05-28	2002-11-29	Bioneris Ab	Användning av en förening med en negativt laddad region av grupper för behandling av restenos.
EP1384708A1 (en) *	2002-07-26	2004-01-28	CHIESI FARMACEUTICI S.p.A.	Process for the manufacture of form I of nolomirole hydrochloride
US20050101668A1 (en) *	2003-07-24	2005-05-12	Chiesi Farmaceutici S.P.A.	Aminotetralin derivatives as a medicament for the treatment and prevention of myocardial ischemic conditions

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US4134997A (en) *	1977-03-01	1979-01-16	University Of Iowa Research Foundation	Effect of an aminotetralin derivative on coronary blood flow in infarcted hearts
SU998342A1 (ru)	1981-12-11	1983-02-23	Предприятие П/Я А-3732	Способ получени синтетического цеолита типа @
IT1218322B (it) *	1982-06-10	1990-04-12	Chiesi Farma Spa	Derivati di 1,2,3,4-tetraidronaftalene,procedimento di preparazione e relative composizioni farmaceutiche

1995
- 1995-03-17 IT IT95MI000532A patent/IT1275935B1/it active IP Right Grant
1996
- 1996-03-13 PT PT96907446T patent/PT814791E/pt unknown
- 1996-03-13 ES ES96907446T patent/ES2177769T3/es not_active Expired - Lifetime
- 1996-03-13 DK DK96907446T patent/DK0814791T3/da active
- 1996-03-13 CA CA002215671A patent/CA2215671A1/en not_active Abandoned
- 1996-03-13 BR BR9607996A patent/BR9607996A/pt not_active Application Discontinuation
- 1996-03-13 PL PL96322284A patent/PL183347B1/pl not_active IP Right Cessation
- 1996-03-13 AT AT96907446T patent/ATE218856T1/de not_active IP Right Cessation
- 1996-03-13 EP EP02001772A patent/EP1216702A3/en not_active Withdrawn
- 1996-03-13 KR KR1019970706438A patent/KR100391143B1/ko not_active Expired - Fee Related
- 1996-03-13 MX MX9706971A patent/MX9706971A/es not_active IP Right Cessation
- 1996-03-13 CN CN96193312A patent/CN1112920C/zh not_active Expired - Fee Related
- 1996-03-13 EE EE9700231A patent/EE04040B1/xx not_active IP Right Cessation
- 1996-03-13 DE DE69621786T patent/DE69621786T2/de not_active Expired - Fee Related
- 1996-03-13 EA EA199700243A patent/EA000937B1/ru not_active IP Right Cessation
- 1996-03-13 NZ NZ303993A patent/NZ303993A/xx unknown
- 1996-03-13 TR TR97/00963T patent/TR199700963T1/xx unknown
- 1996-03-13 SI SI9620036A patent/SI9620036B/sl not_active IP Right Cessation
- 1996-03-13 WO PCT/EP1996/001060 patent/WO1996029065A2/en not_active Ceased
- 1996-03-13 CZ CZ19972866A patent/CZ288488B6/cs not_active IP Right Cessation
- 1996-03-13 EP EP96907446A patent/EP0814791B1/en not_active Expired - Lifetime
- 1996-03-13 JP JP8528045A patent/JPH11502211A/ja not_active Ceased
- 1996-03-13 US US08/913,363 patent/US6013678A/en not_active Expired - Fee Related
- 1996-03-13 AU AU51072/96A patent/AU702656B2/en not_active Ceased
- 1996-03-13 SK SK1254-97A patent/SK282952B6/sk unknown
- 1996-03-13 HU HU9801686A patent/HUP9801686A3/hu unknown
- 1996-03-14 ZA ZA962073A patent/ZA962073B/xx unknown
- 1996-03-17 IL IL11751896A patent/IL117518A/en not_active IP Right Cessation
1997
- 1997-09-15 LV LVP-97-166A patent/LV11882B/en unknown
- 1997-09-15 LT LT97-147A patent/LT4355B/lt not_active IP Right Cessation
- 1997-09-16 NO NO19974267A patent/NO317402B1/no not_active IP Right Cessation
1999
- 1999-06-09 US US09/328,434 patent/US6103760A/en not_active Expired - Fee Related
2002
- 2002-12-19 HK HK02109206.9A patent/HK1048060A1/en unknown

Also Published As

Publication number	Publication date
LV11882B (en)	1998-03-20
SI9620036A (sl)	1998-02-28
AU5107296A (en)	1996-10-08
CN1112920C (zh)	2003-07-02
PL322284A1 (en)	1998-01-19
DE69621786T2 (de)	2003-01-02
LT4355B (lt)	1998-06-25
EP0814791B1 (en)	2002-06-12
AU702656B2 (en)	1999-02-25
NO317402B1 (no)	2004-10-25
CN1181699A (zh)	1998-05-13
PL183347B1 (pl)	2002-06-28
EP1216702A3 (en)	2002-09-04
EA199700243A1 (ru)	1998-02-26
SK282952B6 (sk)	2003-01-09
IL117518A0 (en)	1996-07-23
WO1996029065A3 (en)	1996-11-28
EP1216702A2 (en)	2002-06-26
DE69621786D1 (de)	2002-07-18
CZ288488B6 (en)	2001-06-13
KR19980703030A (ko)	1998-09-05
TR199700963T1 (xx)	1998-02-21
HUP9801686A2 (hu)	1999-06-28
EA000937B1 (ru)	2000-06-26
US6103760A (en)	2000-08-15
CA2215671A1 (en)	1996-09-26
DK0814791T3 (da)	2002-10-07
LT97147A (en)	1998-02-25
HK1048060A1 (en)	2003-03-21
IT1275935B1 (it)	1997-10-24
US6013678A (en)	2000-01-11
ES2177769T3 (es)	2002-12-16
WO1996029065A2 (en)	1996-09-26
EE04040B1 (et)	2003-06-16
NO974267D0 (no)	1997-09-16
KR100391143B1 (ko)	2003-11-28
LV11882A (lv)	1997-12-20
ZA962073B (en)	1996-11-27
EE9700231A (et)	1998-04-15
ITMI950532A0 (it)	1995-03-17
JPH11502211A (ja)	1999-02-23
SK125497A3 (en)	1998-02-04
NZ303993A (en)	2000-12-22
BR9607996A (pt)	1998-06-23
IL117518A (en)	2001-05-20
CZ286697A3 (cs)	1998-03-18
HK1004802A1 (en)	1998-12-11
ITMI950532A1 (it)	1996-09-17
HUP9801686A3 (en)	1999-10-28
EP0814791A1 (en)	1998-01-07
PT814791E (pt)	2002-10-31
MX9706971A (es)	1997-11-29
ATE218856T1 (de)	2002-06-15
SI9620036B (sl)	2002-10-31

Legal Events

Date	Code	Title	Description
2005-11-14	MM1K	Lapsed by not paying the annual fees

Publication	Publication Date	Title
BR9714363A (pt)	2000-03-21	Derivados de pirazol substituìdos para o tratamento de doenças circulatórias cardìacas
HUP9900773A3 (en)	2000-04-28	Use of carbazole derivatives for producing pharmaceutical compositions suitable for the treatment of congestive heart failure
NO20075065L (no)	1999-02-25	Anvendelse av isoflavonforbindelser til a behandle hjertesykdom
ITTO950104A0 (it)	1995-02-15	Catetere, particolarmente per il trattamento di aritmie cardiache.
ITTO950099A0 (it)	1995-02-14	Catetere, particolarmente per il trattamento di aritmie cardiache.
NO951761D0 (no)	1995-05-05	Stabilt preparat for behandling av blodkoagulasjonssykdommer
ATE239474T1 (de)	2003-05-15	Verwendung von levobupivacain
NO880182L (no)	1988-07-20	Fremgangsmaate for fremstilling av terapeutisk aktive 1,2-dihydro-3h-indazol-3-on-derivater.
NO974267D0 (no)	1997-09-16	Aminotetralinderivat for behandling av kardiovaskulære sykdommer
ATE157871T1 (de)	1997-09-15	Arzneimittel zur therapeutischen und prophylaktischen behandlung von krankheiten, die durch hyperplasie der glatten muskelzellen bedingt sind
IS1910B (is)	2003-12-31	Notkun á fankínóni til meðhöndlunar á Alzheimers-sjúkdómi
ATE151774T1 (de)	1997-05-15	Cyclopentanperhydrophenanthren-17-beta-(3-furyl - 3-derivate und pharmazeutische präparate davon, zur behandlung von kardiovaskulär-erkrankungen
TR199901385T2 (xx)	1999-11-22	Piperidin t�revleri.
DK0538690T3 (da)	1995-03-06	Arylquinolyl-substituerede 1,4-dihydropyridin-dicarboxylsyrederivater, fremgangsmåde til deres fremstilling af deres anvendelse i lægemidler
GR3024707T3 (en)	1997-12-31	Digitoxigenin and dihydrodigitoxigenin 3beta-derivatives and pharmaceutical compositions comprising same for the treatment of cardiovascular disorders
ATE236159T1 (de)	2003-04-15	Neuartige bispidin-derivate, die sich zur behandlung von herzrhythmusstörungen eignen
DK0710646T3 (da)	1999-06-23	1,5-Disubstituerede 7a-methylperhydroinden-3a-olderivater, der er aktive på det cardiovaskulære system, fremgangsmåder til
AU4016189A (en)	1990-03-01	Use of 2-azabicyclo(2.2.2) octane-3-carboxylic acid derivatives for the production of medicinal products intended for the treatment of diseases resulting from impairment of the vascular wall as well as for disorders of the microcirculation
HU0300170D0 (en)	2003-03-28	Use of carbazole derivatives for producing pharmaceutical compositions suitable for the treatment of congestive heart failure
ITMI950956A0 (it)	1995-05-12	Uso degli enantiomeri (s) di derivati 1,4-diidropiridinici per il trattamento dell'insufficienza cardiaca